Annual Operating Margin
N/A
December 31, 2023
Summary
- IKT annual operating profit margin is not available.
Performance
IKT Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Margin
N/A
September 30, 2024
Summary
- IKT quarterly operating profit margin is not available.
Performance
IKT Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
IKT Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
IKT Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Inhibikase Therapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -1361.22%(+605.9%) |
| Jun 2021 | - | -192.83%(+3.4%) |
| Mar 2021 | - | -186.56%(-73.5%) |
| Dec 2020 | -403.52% | -704.66%(-60.0%) |
| Sep 2020 | - | -1761.44%(+834.5%) |
| Jun 2020 | - | -188.50%(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -199.42%(+13.5%) |
| Dec 2019 | -507.52%(+866.3%) | -175.74%(-81.8%) |
| Sep 2019 | - | -968.09%(-30.9%) |
| Jun 2019 | - | -1400.95%(+377.9%) |
| Mar 2019 | - | -293.12% |
| Dec 2018 | -52.52% | - |
FAQ
- What is the all time high annual operating margin for Inhibikase Therapeutics?
- What is the all time high quarterly operating margin for Inhibikase Therapeutics?
What is the all time high annual operating margin for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual operating profit margin is -52.52%
What is the all time high quarterly operating margin for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly operating profit margin is -175.74%